7O7F

Structural basis of the activation of the CC chemokine receptor 5 by a chemokine agonist

7O7F の概要

• エントリーDOI: 10.2210/pdb7o7f/pdb
• EMDBエントリー: 12746
• 分子名称: Guanine nucleotide-binding protein G(i) subunit alpha-1, Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1, C-C chemokine receptor type 5, ... (7 entities in total)
• 機能のキーワード: g protein-coupled receptor (gpcr); ccr5; ccl5/rantes; hiv entry; aids; membrane protein structure;, membrane protein, signaling protein
• 由来する生物種: Homo sapiens (Human); 詳細
• タンパク質・核酸の鎖数: 7
• 化学式量合計: 184436.01

構造登録者

Isaikina, P.,Tsai, C.-J.,Dietz, N.B.,Pamula, F.,Goldie, K.N.,Schertler, G.F.X.,Maier, T.,Stahlberg, H.,Deupi, X.,Grzesiek, S. (登録日: 2021-04-13, 公開日: 2021-06-30, 最終更新日: 2024-10-23)

主引用文献

Isaikina, P.,Tsai, C.J.,Dietz, N.,Pamula, F.,Grahl, A.,Goldie, K.N.,Guixa-Gonzalez, R.,Branco, C.,Paolini-Bertrand, M.,Calo, N.,Cerini, F.,Schertler, G.F.X.,Hartley, O.,Stahlberg, H.,Maier, T.,Deupi, X.,Grzesiek, S.
Structural basis of the activation of the CC chemokine receptor 5 by a chemokine agonist.
Sci Adv, 7:-, 2021

PubMed Abstract: The human CC chemokine receptor 5 (CCR5) is a G protein-coupled receptor (GPCR) that plays a major role in inflammation and is involved in cancer, HIV, and COVID-19. Despite its importance as a drug target, the molecular activation mechanism of CCR5, i.e., how chemokine agonists transduce the activation signal through the receptor, is yet unknown. Here, we report the cryo-EM structure of wild-type CCR5 in an active conformation bound to the chemokine super-agonist [6P4]CCL5 and the heterotrimeric G protein. The structure provides the rationale for the sequence-activity relation of agonist and antagonist chemokines. The N terminus of agonist chemokines pushes onto specific structural motifs at the bottom of the orthosteric pocket that activate the canonical GPCR microswitch network. This activation mechanism differs substantially from other CC chemokine receptors that bind chemokines with shorter N termini in a shallow binding mode involving unique sequence signatures and a specialized activation mechanism.

PubMed: 34134983
DOI: 10.1126/sciadv.abg8685

実験手法

ELECTRON MICROSCOPY (3.15 Å)